IGM Biosciences, Inc.
IGMS
$1.28
$0.064.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -195.80M | -219.84M | -220.40M | -236.92M | -246.42M |
| Total Depreciation and Amortization | 9.11M | 8.94M | 8.89M | 8.79M | 8.28M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.79M | 45.64M | 43.37M | 49.22M | 52.60M |
| Change in Net Operating Assets | -7.11M | -920.00K | 220.00K | -4.74M | -6.69M |
| Cash from Operations | -153.00M | -166.18M | -167.92M | -183.65M | -192.23M |
| Capital Expenditure | -5.85M | -6.44M | -8.23M | -10.93M | -12.38M |
| Sale of Property, Plant, and Equipment | 39.00K | 39.00K | 32.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.97M | 37.87M | 46.23M | 18.11M | 80.74M |
| Cash from Investing | 64.16M | 31.47M | 38.03M | 7.18M | 68.36M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.46M | 2.44M | 45.88M | 115.19M | 115.07M |
| Repurchase of Common Stock | -1.00K | -1.00K | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -71.00K | -71.00K | -71.00K | -40.00K | -- |
| Cash from Financing | 2.39M | 2.37M | 45.81M | 115.15M | 115.07M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -86.45M | -132.35M | -84.08M | -61.32M | -8.81M |